PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized chemo dosing may boost survival in kids with High-Risk leukemia
⭐️ CURE ⭐️ Recruiting nowThis nationwide trial is testing whether adjusting chemotherapy intensity based on the amount of leukemia cells remaining after initial treatment (called minimal residual disease, or MRD) can improve outcomes for children and teens with high-risk acute lymphoblastic leukemia (ALL…
Matched conditions: PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Jae Wook Lee • Aim: ⭐️ CURE ⭐️
Last updated Jul 31, 2026 00:00 UTC
-
New hope for Tough-to-Treat blood cancer: MK-1045 enters human trials
Disease control Recruiting nowThis study tests a new drug called MK-1045 (CN201) in people with a type of blood cancer (B-cell acute lymphoblastic leukemia) that has come back or stopped responding to treatment. The trial has two parts: first, finding a safe dose, and then checking how well the drug works. Ab…
Matched conditions: PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: MSD R&D (China) Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC